Metformin is associated with 90-day decreased risk of death and AKI after shoulder arthroplasty in diabetic patients. // Journal of Orthopaedics. – URL: https://www.sciencedirect.com/science/article/pii/S0972978X26001339?dgcid=rss_sd_all
Metformin is associated with 90-day decreased risk of death and AKI after shoulder arthroplasty in diabetic patients. Journal of Orthopaedics. https://www.sciencedirect.com/science/article/pii/S0972978X26001339?dgcid=rss_sd_all
“Metformin is associated with 90-day decreased risk of death and AKI after shoulder arthroplasty in diabetic patients.” Journal of Orthopaedics.
@article{article54976,
title = {Metformin is associated with 90-day decreased risk of death and AKI after shoulder arthroplasty in diabetic patients},
journal = {Journal of Orthopaedics},
url = {https://www.sciencedirect.com/science/article/pii/S0972978X26001339?dgcid=rss_sd_all}
}